About Lee Schoentrup

This author has not yet filled in any details.
So far Lee Schoentrup has created 112 blog entries.

Publication Details IDRI’s Promising Leprosy Vaccine Candidate

April 26th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 26, 2018: A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI’s leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection [...]

The World’s Most Dangerous Creature

April 25th, 2018|Blog|

When asked about the deadliest creatures in the world, thoughts often turn to sharks, snakes or even lions. But the list is topped by a tiny, buzzing insect that packs a powerful punch: the mosquito, which transmits parasites that cause [...]

IDRI Names New Chief Operating Officer and Chief Scientific Officer

April 6th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 6, 2018: As IDRI (Infectious Disease Research Institute) celebrates its 25th anniversary in 2018, the organization is developing a strategic plan to hone current strengths while embarking upon bold new initiatives including next generation [...]

New Vaccine Could Stop TB from Becoming Active

April 3rd, 2018|News|

Bike Everywhere Day 2018

April 3rd, 2018|Events|

May 18, 2018 Bike Everywhere Day 2018 6-9 a.m., Friday, May 18, 2018 1616 Eastlake Avenue East, Seattle, WA IDRI (Infectious Disease Research Institute), Grand Central Bakery, Alexandria Real Estate, the local chapter of the MS Society & Caliber Home [...]

New $3.2 Million Grant Funds Research to Advance Promising Malaria Vaccine

March 29th, 2018|News|

New Vaccine May Prevent TB Progression

March 29th, 2018|News|

IDRI Partners to Develop a New Vaccine to Prevent Transmission of Malaria

March 29th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 29, 2018: The Global Health Innovative Technology Fund (GHIT) has awarded the University of Florida (UF) and partners, including IDRI (Infectious Disease Research Institute), $3.2 million to advance a promising vaccine to prevent transmission [...]

IDRI TB Vaccine Candidate Shows Success in Initial Trial

March 24th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 24, 2018 : Researchers at IDRI (Infectious Disease Research Institute), the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT) and Aeras have released the first results from a clinical trial [...]

IDRI Receives $3.8 Million for TB Drug Discovery

March 23rd, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | March 23, 2018: IDRI’s tuberculosis drug discovery efforts continue to expand with a recently awarded grant extension of $3.8 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya [...]

Load More